Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?

Sipahi Çimen Sevgi; Altınel Zeynep

doi:https://dx.doi.org/10.5222/j.child.2017.139

Araştırma Makalesi

DOI :10.5222/j.child.2017.139 IUP :10.5222/j.child.2017.139 Tam Metin (PDF)

Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?

Anafilaksi YAŞAMI tehdit eden acil bir durumdur, hızla tanı konulup tedavisine başlanmalıdır. Anafilaksi tedavisinde ilk seçenek adrenalindir; ölüm ve hastaneye yatışı önleyen tek ilaçtır. Anafilaksinin ne zaman ortaya çıkacağı öngörülemediğinden tedavisi kadar önlenmesi de çok önemlidir. Bu nedenle anafilaksi geçiren ve anafilaksi riski yüksek olan bireylere adrenalin oto-enjektörleri (AOE) reçete edilmeli, hangi durumlarda ve nasıl kullanacakları hakkında bilgi verilmelidir. Genel olarak anafilakside adrenalin kullanımı, çocuklarda ve erişkinlerde, yetersiz kalmakta, AOE risk altındaki hastalarda düşük oranda reçetelenmektedir

Anahtar Kelimeler: Anafilaksi, adrenalin oto-enjektör, tedavi, eğitim

DOI :10.5222/j.child.2017.139 IUP :10.5222/j.child.2017.139 Tam Metin (PDF)

How Much We Know about the Use of Adrenaline in Anaphylaxis?

Sevgi Sipahi Çimen, Zeynep Altınel

Anaphylaxis is a life-threatening, emergency clinic condition, so it is essential to diagnose and treat anaphylaxis immediately. Adrenaline is the first choice in the treatment of anaphylaxis; it is the only drug that prevents death and hospitalization. It is also very important to prevent anaphylaxis as much as treatment, since it is not predictable when it will appear. Adrenaline auto-injectors (AAI) should be prescribed for individuals who have anaphylaxis and are at high risk for anaphylaxis, and they should be informed about when and how to use them. Generally, in adult and pediatric patients, administration of adrenaline in anaphylactic reactions is inadequate and AAI is prescribed at low rates for patients at risk of anaphylaxis.

Anahtar Kelimeler: Anaphylaxis, adrenaline auto-injector, treatment, education

Referanslar

1. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 2006;47(4):373-80. https://doi.org/10.1016/j.annemergmed.2006.01.018 google scholar
2. Rudders SA, Arias SA, Camargo CA Jr. Trends in hospitalizations for food-induced anaphylaxis in US children, 2000-2009. J Allergy Clin Immunol 2014; 134(4):960-2. https://doi.org/10.1016/j.jaci.2014.06.018 google scholar
3. Lee S, Hess EP, Lohse C, Gilani W, Chamberlain AM, Campbell RL. Trends, characteristics, and incidence of anaphylaxis in 2001-2010: A populationbased study. J Allergy Clin Immunol 2017;139(1):182- 188. S. Sipahi ve Z. Ü. Tamay, Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor? 143 https://doi.org/10.1016/j.jaci.2016.04.029 google scholar
4. Calvani M, Cardinale F, Martelli A, Muraro A, Pucci N, Savino F, et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011;22(8):813-9. https://doi.org/10.1111/j.1399-3038.2011.01200.x google scholar
5. González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LA. Anaphylaxis epidemiology in patients withand patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010;125(5): 1098-104. https://doi.org/10.1016/j.jaci.2010.02.009 google scholar
6. Nwaru BI, Dhami S, Sheikh A. Idiopathic anaphylaxis. Curr Treat Options Allergy 2017;4(3):312-9. https://doi.org/10.1007/s40521-017-0136-2 google scholar
7. Simons FER, Ardusso LRF, Bilo MB, El- Gamal YM, Ledford DK, Ring J et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol 2011;127:587-93. https://doi.org/10.1016/j.jaci.2011.01.038 google scholar
8. Westfall TC. Adrenergic agonists and antagonists. In: Chabner BA, Brunton LL, Knollmann BC, editors. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 2006: 215- 268. google scholar
9. Muraro A, Roberts G, ClarkA, et al. The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology Allergy 2007;62:857-71. google scholar
10. Soreide EB. Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment. Acta Anaesthesiol Scand 1988;32:339-42. https://doi.org/10.1111/j.1399-6576.1988.tb02740.x google scholar
11. Kaplan AP. Anaphylaxis. In: Goldman L, Bennett JC, editors. Ceciltextbook of medicine. 21st ed. Philadelphia: WB Saunders; 2000:1450-2. google scholar
12. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy ClinImmunol 1998;101(1 Pt 1):33-7. https://doi.org/10.1016/S0091-6749(98)70190-3 google scholar
13. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001;108(5):871-3. https://doi.org/10.1067/mai.2001.119409 google scholar
14. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 2003;3:313-8. https://doi.org/10.1097/00130832-200308000-00013 google scholar
15. Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res 2011;31(1):61-75. https://doi.org/10.1016/j.nutres.2011.01.001 google scholar
16. Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008;63(8):1061- 70. https://doi.org/10.1111/j.1398-9995.2008.01733.x google scholar
17. Simons KJ, Simons FER. Epinephrine and its use in anaphylaxis: current issues. CurrOpin Allergy ClinImmunol. 2010;10:354–361. https://doi.org/10.1097/ACI.0b013e32833bc670 google scholar
18. Rudders SA, Banerji A, Corel B, Clark S, Camargo CA Jr. Multicenterstudy of repeat epinephrine treatments for food-related anaphylaxis. Pediatrics 2010;125(4):e711-8. https://doi.org/10.1542/peds.2009-2832 google scholar
19. Grossman SL, Baumann BM, GarciaPe-a BM, Linares MY, Greenberg B, Hernandez-Trujillo VP. Anaphylaxis knowledge and practice preferences of pediatric emergency medicine physicians: a national survey. J Pediatr 2013;163(3):841-6. https://doi.org/10.1016/j.jpeds.2013.02.050 google scholar
20. Simons FER, Gu X, Silver NA, Simons KJ. EpiPenJr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis. J Allergy Clin Immunol 2002;109:171-5. https://doi.org/10.1067/mai.2002.120758 google scholar
21. Ercan H, Ozen A, Karatepe H, Berber M, Cengizlier R. Primary school teachers’ knowledge about and attitudes toward anaphylaxis. Pediatr Allergy Immunol 2012;23(5):428-32. https://doi.org/10.1111/j.1399-3038.2012.01307.x google scholar
22. Flokstra-de Blok BM, Doriene van Ginkel C, Roerdink EM, Kroeze MA, Stel AA, van der Meulen GN, et al. Extremely low prevalence of epinephrine autoinjectors in high-risk food-allergic adolescents in Dutch high schools. Pediatr Allergy Immuno1 2011; 22:374-7. google scholar
23. Johnson MJ, Foote KD, Moyses HE, Roberts G. Practices in the prescription of adrenaline autoinjectors. Pediatr Allergy Immunol 2012;23:124-7. https://doi.org/10.1111/j.1399-3038.2011.01221.x google scholar
24. Larcan A, Moneret-Vautrin DA. The use of adrenaline for thetreatment of anaphylaxis: the use by first-aid personnel is recommended. Presse Med 2013;42(6 Pt 1):922-9. https://doi.org/10.1016/j.lpm.2012.11.012 google scholar
25. Calamelli E, Mattana F, Cipriani F, Ricci G. Management and treatment of anaphylaxis in children: still too low the rate of prescription and administration of intramuscular epinephrine. Int J Immunopathol Pharmacol 2014;27(4):597-605. https://doi.org/10.1177/03946320140270041 google scholar
26. Robinson M, Greenhawt M, Stukus DR. Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department. Ann Allergy Asthma Immunol 2017;119 (2):164-9. https://doi.org/10.1016/j.anai.2017.06.001 google scholar
27. Grouhi M, Alshehri M, Hummel D, Roifman CM. Anaphylaxis and epinephrine auto-injector training: who will teach the teachers? J Allergy Clin Immunol 1999;104:190-3. https://doi.org/10.1016/S0091-6749(99)70134-X google scholar
28. Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 2000;105:359- 62. https://doi.org/10.1542/peds.105.2.359 google scholar
29. Campbell RL, Bellolio MF, Knutson BD, Bellamkonda VR, Fedko MG, Nestler DM, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intra- Çocuk Dergisi 2017; 17(4):139-144 144 muscular epinephrine. J Allergy Clin Immunol Pract 2015;3:76-80. https://doi.org/10.1016/j.jaip.2014.06.007 google scholar
30. Gaeta JT, Clark S, Pelletier AJ, Camargo CA. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol 2007;98:360-5. https://doi.org/10.1016/S1081-1206(10)60883-6 google scholar
31. Medicines and Health Products Regulatory Agency. Adrenaline auto-injectors: a review of clinical and quality considerations. 2014. google scholar
32. Fuzak JK, Trainor J. Comparison of the incidence, etiology, and management of anaphylaxis over time. Pediatr Emerg Care 2013;29(2):131-5. https://doi.org/10.1097/PEC.0b013e31828058cd google scholar
33. Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but noincrease in fatalities: an analysis of United Kingdom nationalan aphylaxis data, 1992-2012. J Allergy Clin Immunol 2015;135(4):956-63. https://doi.org/10.1016/j.jaci.2014.10.021 google scholar
34. Diwakar L, Cummins C, Ryan R, Marshall T, Roberts T. Prescription rates of adrenaline autoinjectors for children in UK general practice: a retrospective cohort study. Br J Gen Pract 2017;67(657):e300- e305. https://doi.org/10.3399/bjgp17X689917 35. Topal E, Bakirtas A, Yilmaz O, Ertoy IH, Arga M, Demirsoy MS, et al. A real-life study on acquired skills from using an adrenaline autoinjector. Int Arch Allergy Immunol 2013;160(3):301-6. https://doi.org/10.1159/000341367 google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın

DIŞA AKTAR

APA

Sipahi Çimen, S., & Altınel, Z. (0001). Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?. Çocuk Dergisi, 17(4), 139-144. https://doi.org/10.5222/j.child.2017.139

AMA

Sipahi Çimen S, Altınel Z. Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?. Çocuk Dergisi. 0001;17(4):139-144. https://doi.org/10.5222/j.child.2017.139

ABNT

Sipahi Çimen, S.; Altınel, Z. Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?. Çocuk Dergisi, [Publisher Location], v. 17, n. 4, p. 139-144, 0001.

Chicago: Author-Date Style

Sipahi Çimen, Sevgi, and Zeynep Altınel. 0001. “Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?.” Çocuk Dergisi 17, no. 4: 139-144. https://doi.org/10.5222/j.child.2017.139

Chicago: Humanities Style

Sipahi Çimen, Sevgi, and Zeynep Altınel. “Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?.” Çocuk Dergisi 17, no. 4 (Nov. 2024): 139-144. https://doi.org/10.5222/j.child.2017.139

Harvard: Australian Style

Sipahi Çimen, S & Altınel, Z 0001, 'Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?', Çocuk Dergisi, vol. 17, no. 4, pp. 139-144, viewed 23 Nov. 2024, https://doi.org/10.5222/j.child.2017.139

Harvard: Author-Date Style

Sipahi Çimen, S. and Altınel, Z. (0001) ‘Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?’, Çocuk Dergisi, 17(4), pp. 139-144. https://doi.org/10.5222/j.child.2017.139 (23 Nov. 2024).

MLA

Sipahi Çimen, Sevgi, and Zeynep Altınel. “Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?.” Çocuk Dergisi, vol. 17, no. 4, 0001, pp. 139-144. [Database Container], https://doi.org/10.5222/j.child.2017.139

Vancouver

Sipahi Çimen S, Altınel Z. Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?. Çocuk Dergisi [Internet]. 23 Nov. 2024 [cited 23 Nov. 2024];17(4):139-144. Available from: https://doi.org/10.5222/j.child.2017.139 doi: 10.5222/j.child.2017.139

ISNAD

Sipahi Çimen, Sevgi - Altınel, Zeynep. “Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?”. Çocuk Dergisi 17/4 (Nov. 2024): 139-144. https://doi.org/10.5222/j.child.2017.139

Cilt 17, Sayı 42017, S. 139-144

ZAMAN ÇİZELGESİ

LİSANS

Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.

Çocuk Dergisi

Araştırma Makalesi

Anafilakside Adrenalin Kullanımı: Ne Kadar Biliniyor?

How Much We Know about the Use of Adrenaline in Anaphylaxis?

PDF Görünüm

Referanslar

Atıflar

DIŞA AKTAR

APA

AMA

ABNT

Chicago: Author-Date Style

Chicago: Humanities Style

Harvard: Australian Style

Harvard: Author-Date Style

MLA

Vancouver

ISNAD

ZAMAN ÇİZELGESİ

LİSANS

PAYLAŞ